159275-17-9 Usage
General Description
BENZYL 4-(BROMOMETHYL)TETRAHYDRO-1(2H)-PYRIDINECARBOXYLATE is a chemical compound with the molecular formula C15H18BrNO2. It is a derivative of tetrahydropyridine and is commonly used in organic synthesis as a reagent. BENZYL 4-(BROMOMETHYL)TETRAHYDRO-1(2H)-PYRIDINECARBOXYLATE is known for its versatile application in the production of pharmaceuticals, agrochemicals, and other fine chemicals. It is often utilized as a building block in the synthesis of various biologically active compounds. Additionally, BENZYL 4-(BROMOMETHYL)TETRAHYDRO-1(2H)-PYRIDINECARBOXYLATE is valued for its ability to introduce the bromomethyl group into organic molecules, making it an important intermediate in the creation of diverse chemical structures.
Check Digit Verification of cas no
The CAS Registry Mumber 159275-17-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,5,9,2,7 and 5 respectively; the second part has 2 digits, 1 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 159275-17:
(8*1)+(7*5)+(6*9)+(5*2)+(4*7)+(3*5)+(2*1)+(1*7)=159
159 % 10 = 9
So 159275-17-9 is a valid CAS Registry Number.
InChI:InChI=1/C14H18BrNO2/c15-10-12-6-8-16(9-7-12)14(17)18-11-13-4-2-1-3-5-13/h1-5,12H,6-11H2
159275-17-9Relevant articles and documents
LMP7 INHIBITORS
-
Page/Page column 82, (2016/04/26)
The present disclosure provides compounds that are Large Multifunctional Protease 7 (LMP7) inhibitors and are therefore useful for the treatment of diseases treatable by inhibition of LMP7. Also provided are pharmaceutical compositions containing such compounds and processes for preparing such compounds.
Amidine compounds
-
, (2008/06/13)
A compound of the formula [I] wherein R1, R2and R3are the same or different and each is hydrogen atom, wherein each symbol is as defined in the specification, a salt thereof or a prodrug thereof. The compound of the presen
Phosphonic acid derivatives
-
, (2008/06/13)
A phosphonic acid derivative which is useful for medically treating hyperlipemia, represented by the following general formula (I) or a pharmacologically acceptable salt thereof: STR1 Representative example of the compound according to the present invention is one represented by the following formula: STR2